HSIC Henry Schein, Inc. - Common Stock
Henry Schein, Inc. - Common Stock 정보 위키백과 회사 개요
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
더 보기
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
HSIC 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
HSIC 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
HSIC 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 7 28.0%
- 매수 7 28.0%
- 보유 10 40.0%
- 매도 1 4.0%
- 적극 매도 0 0.0%
12개월 목표 주가
16 명의 애널리스트 · 2026-08-19실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $1.27 | $1.26 | 0.01% |
| 2026년 3월 31일 | $1.32 | $1.24 | 0.08% |
| 2025년 12월 31일 | $1.34 | $1.33 | 0.01% |
| 2025년 9월 30일 | $1.38 | $1.30 | 0.08% |
| 2025년 6월 30일 | $1.10 | $1.22 | -0.12% |
| 2025년 3월 31일 | $1.15 | $1.13 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
현금 흐름 19
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
성장률 9
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | -245,089,515 | 120,199,552 | 121,927,867 | 123,776,073 | -255,840,759 | 126,124,715 | 127,784,380 | 128,720,661 | -269,727 | 130,388,353 | 131,365,789 | -274,191,526 | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | -246,803,540 | 121,036,247 | 122,636,948 | 124,848,221 | -257,691,792 | 127,054,934 | 128,646,506 | 129,769,580 | -401,001 | 131,442,135 | 133,039,886 | -277,434,915 | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
현금 흐름 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.40B | $13.12B | · | $12.92B | $12.72B | $12.65B | · | $12.64B | $12.57B | $12.49B | · | $12.39B | $12.34B | · | $12.45B | |
| Net Income TTM | $388M | $404M | · | $396M | $399M | $406M | · | $433M | $474M | $491M | · | $548M | $612M | · | $653M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 25.9 | 21.6 | · | 20.6 | 23.2 | 21.6 | · | 21.9 | 17.7 | 20.2 | · | 18.1 | 18.3 | · | 14.3 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| P / FCF | · | -67.6 | · | · | · | 1398.1 | · | · | · | 62.2 | · | · | · | · | · | |
| EV / EBITDA | 40.7 | 34.8 | · | 35.3 | 64.2 | 36.8 | · | 61.6 | 53.5 | 44.0 | · | 47.5 | · | · | · | |
| EV / FCF | · | -75.1 | · | · | · | 1521.4 | · | · | · | 62.9 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.8 | · | · | · | |
| Earnings Yield | 3.9% | 4.6% | · | 4.8% | 4.3% | 4.6% | · | 4.6% | 5.7% | 5.0% | · | 5.5% | 5.5% | · | 7.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 매출 | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| 매출 총이익률 % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| 영업이익률 % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| 순이익 | $398M | $390M | $416M | $538M | $631M |
| 희석 EPS | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
대차대조표
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| 유동비율 | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| 당좌 비율 | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
현금 흐름
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $573M | $700M | $353M | $506M | $631M |
최신 뉴스 이 회사 관련 최근 헤드라인
트레이딩 시그널 진입 가격 및 위험/보상 비율을 포함한 최근 매수/매도 신호
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 603개의 제출자 · $7.6B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 68 (-4 이전 분기 대비) | 60 (+14 이전 분기 대비) | 172 (-5 이전 분기 대비) | 203 (+21 이전 분기 대비) | +14.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1,307,257,713 | 15,652,032 | 17.12% | 주식 |
| Artisan Partners Limited Partnership | $540,162,844 | 6,467,467 | 7.07% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $530,073,795 | 6,346,669 | 6.94% | 주식 |
| STATE STREET CORP | $359,576,652 | 4,305,276 | 4.71% | 주식 |
| FMR LLC | $349,717,366 | 4,187,229 | 4.58% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345,225,076 | 4,133,442 | 4.52% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $288,743,396 | 3,457,175 | 3.78% | 주식 |
| Southpoint Capital Advisors LP | $275,616,000 | 3,300,000 | 3.61% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $256,689,867 | 3,073,394 | 3.36% | 주식 |
| CITADEL ADVISORS LLC | $243,970,272 | 2,921,100 | 3.20% | 주식 |
| Palestra Capital Management LLC | $204,347,632 | 2,446,691 | 2.68% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $200,544,294 | 2,405,837 | 2.63% | 주식 |
| FIDUCIARY MANAGEMENT INC /WI/ | $151,785,323 | 1,817,353 | 1.99% | 주식 |
| Burgundy Asset Management Ltd. | $151,049,204 | 2,170,871 | 1.98% | 주식 |
| LYRICAL ASSET MANAGEMENT LP | $122,553,156 | 1,467,351 | 1.60% | 주식 |
| Swedbank AB | $109,479,854 | 1,310,822 | 1.43% | 주식 |
| M.D. Sass, LLC | $107,485,396 | 1,286,942 | 1.41% | 주식 |
| SNYDER CAPITAL MANAGEMENT L P | $107,341,992 | 1,285,225 | 1.41% | 주식 |
| NORGES BANK | $103,383,729 | 1,237,832 | 1.35% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86,592,951 | 1,036,793 | 1.13% | 주식 |
| NOMURA HOLDINGS INC | $77,065,658 | 922,721 | 1.01% | 주식 |
| PZENA INVESTMENT MANAGEMENT LLC | $71,888,420 | 860,733 | 0.94% | 주식 |
| Ananym Capital Management, LP | $57,978,164 | 694,183 | 0.76% | 주식 |
| Ulysses Management LLC | $55,570,700 | 665,358 | 0.73% | 주식 |
| STALEY CAPITAL ADVISERS INC | $55,252,489 | 661,548 | 0.72% | 주식 |
| DME Capital Management, LP | $52,173,274 | 624,680 | 0.68% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $45,489,502 | 544,654 | 0.60% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35,970,895 | 430,686 | 0.47% | 주식 |
| GOLDMAN SACHS GROUP INC | $35,392,853 | 423,765 | 0.46% | 주식 |
| Clarkston Capital Partners, LLC | $35,168,100 | 421,074 | 0.46% | 주식 |
| LONE PEAK GLOBAL INVESTORS LLC | $33,404,158 | 399,954 | 0.44% | 주식 |
| GAMCO INVESTORS, INC. ET AL | $30,537,668 | 365,633 | 0.40% | 주식 |
| PRIVATE MANAGEMENT GROUP INC | $27,285,483 | 326,694 | 0.36% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $25,194,142 | 301,654 | 0.33% | 주식 |
| BlackRock, Inc. | $24,670,305 | 295,382 | 0.32% | 주식 |
| GABELLI FUNDS LLC | $24,182,047 | 289,536 | 0.32% | 주식 |
| Zuckerman Investment Group, LLC | $24,062,613 | 288,106 | 0.32% | 주식 |
| JANE STREET GROUP, LLC | $22,976,352 | 275,100 | 0.30% | 콜 옵션 |
| Petrus Trust Company, LTA | $22,550,400 | 270,000 | 0.30% | 주식 |
| P2 Capital Partners, LLC | $22,089,871 | 264,486 | 0.29% | 주식 |
| BANK OF AMERICA CORP /DE/ | $21,414,277 | 256,397 | 0.28% | 주식 |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $21,151,189 | 253,247 | 0.28% | 주식 |
| RHUMBLINE ADVISERS | $21,008,017 | 251,534 | 0.28% | 주식 |
| UBS Group AG | $20,880,000 | 250,000 | 0.27% | 풋 옵션 |
| LAZARD ASSET MANAGEMENT LLC | $20,493,720 | 245,375 | 0.27% | 주식 |
| Cresset Asset Management, LLC | $20,165,236 | 241,442 | 0.26% | 주식 |
| Balyasny Asset Management L.P. | $19,401,863 | 232,302 | 0.25% | 주식 |
| Quantinno Capital Management LP | $18,131,858 | 217,096 | 0.24% | 주식 |
| Vanguard Global Advisers, LLC | $17,149,245 | 205,331 | 0.22% | 주식 |
| FIRST TRUST ADVISORS LP | $16,585,245 | 198,579 | 0.22% | 주식 |
| EVERETT HARRIS & CO /CA/ | $16,551,743 | 198,177 | 0.22% | 주식 |
| California Public Employees Retirement System | $16,351,212 | 195,776 | 0.21% | 주식 |
| Swiss National Bank | $16,344,864 | 195,700 | 0.21% | 주식 |
| Leith Wheeler Investment Counsel Ltd. | $15,975,960 | 191,283 | 0.21% | 주식 |
| WESTWOOD HOLDINGS GROUP INC | $15,708,859 | 188,085 | 0.21% | 주식 |
| Woodline Partners LP | $15,637,951 | 187,236 | 0.20% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14,874,912 | 178,100 | 0.19% | 콜 옵션 |
| Amundi | $14,369,366 | 172,047 | 0.19% | 주식 |
| Stephens Investment Management Group LLC | $14,100,765 | 168,831 | 0.18% | 주식 |
| NUANCE INVESTMENTS, LLC | $14,045,116 | 168,165 | 0.18% | 주식 |
| JANE STREET GROUP, LLC | $13,541,515 | 162,135 | 0.18% | 주식 |
| BARCLAYS PLC | $12,852,476 | 153,885 | 0.17% | 주식 |
| James J. Burns & Company, LLC | $12,843,455 | 153,777 | 0.17% | 주식 |
| Ulysses Management LLC | $12,528,000 | 150,000 | 0.16% | 콜 옵션 |
| Marathon Asset Management Ltd | $11,609,195 | 139,002 | 0.15% | 주식 |
| CLARK ESTATES INC/NY | $11,275,200 | 135,000 | 0.15% | 주식 |
| PFM Health Sciences, LP | $11,227,009 | 134,423 | 0.15% | 주식 |
| Holocene Advisors, LP | $10,191,528 | 122,025 | 0.13% | 주식 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $10,070,173 | 120,572 | 0.13% | 주식 |
| HEARTLAND ADVISORS INC | $10,022,400 | 120,000 | 0.13% | 주식 |
| BANK OF NOVA SCOTIA | $9,519,692 | 113,981 | 0.12% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $9,502,822 | 113,779 | 0.12% | 주식 |
| HFR Wealth Management, LLC | $9,454,965 | 113,206 | 0.12% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9,138,210 | 123,992 | 0.12% | 주식 |
| Illinois Municipal Retirement Fund | $8,914,173 | 106,731 | 0.12% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $8,898,137 | 106,539 | 0.12% | 주식 |
| Clearline Capital LP | $8,696,854 | 104,129 | 0.11% | 주식 |
| Stenger Family Office, LLC | $8,511,793 | 24,721 | 0.11% | 주식 |
| FIRST MANHATTAN CO. LLC. | $8,509,769 | 101,889 | 0.11% | 주식 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8,184,793 | 97,998 | 0.11% | 주식 |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $8,101,440 | 97,000 | 0.11% | 주식 |
| Man Group plc | $7,975,325 | 95,490 | 0.10% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $7,705,472 | 92,259 | 0.10% | 주식 |
| BANYAN CAPITAL MANAGEMENT, INC. | $7,621,951 | 91,259 | 0.10% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $7,521,178 | 90,052 | 0.10% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $6,802,084 | 81,443 | 0.09% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $6,719,450 | 91,173 | 0.09% | 주식 |
| FRANKLIN RESOURCES INC | $6,613,615 | 79,186 | 0.09% | 주식 |
| Berger Financial Group, Inc | $6,535,023 | 78,245 | 0.09% | 주식 |
| WINTON GROUP Ltd | $6,439,392 | 77,100 | 0.08% | 주식 |
| RIVER GLOBAL INVESTORS LLP | $6,404,253 | 92,547 | 0.08% | 주식 |
| Brandywine Global Investment Management, LLC | $6,305,262 | 83,425 | 0.08% | 주식 |
| Foyston, Gordon & Payne Inc | $6,304,173 | 75,481 | 0.08% | 주식 |
| Allianz Asset Management GmbH | $6,210,714 | 74,362 | 0.08% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6,145,736 | 73,584 | 0.08% | 주식 |
| AdvisorShares Investments LLC | $5,879,892 | 70,401 | 0.08% | 주식 |
| PNC Financial Services Group, Inc. | $5,687,294 | 68,095 | 0.07% | 주식 |
| Squarepoint Ops LLC | $5,369,083 | 64,285 | 0.07% | 주식 |
| Cinctive Capital Management LP | $5,110,088 | 61,184 | 0.07% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $4,965,598 | 59,454 | 0.07% | 주식 |
회사 내부자 51 명의 내부자 · 23 임원 · 21 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 2025년 12월 10일 F | 65,900 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 2025년 3월 19일 S | 62,688 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 2025년 3월 14일 D | 36,257 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 2023년 6월 12일 S | 68,690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2018년 3월 2일 A | 62,902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 2016년 3월 15일 S | 31,000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 2025년 3월 14일 D | 81,374 | 0 | 0 | $0 |
| James P Breslawski | President | 2025년 3월 14일 D | 200,227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 2017년 3월 6일 A | 9,654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 2013년 3월 7일 M | 48,716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 2025년 11월 19일 G | 101,622 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 2026년 3월 16일 F | 98,372 | 0 | 2 | $-478,758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 2025년 3월 14일 D | 43,191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 2024년 9월 6일 S | 71,833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 2022년 5월 26일 S | 95,616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 2018년 11월 30일 S | 68,012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 2017년 9월 6일 S | 17,841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 2017년 5월 12일 S | 22,943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 2017년 3월 20일 M | 23,088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 2017년 3월 13일 S | 14,277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 2017년 3월 8일 S | 16,589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2016년 3월 2일 F | 25,144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 2015년 3월 17일 S | 12,343 | 0 | 0 | $0 |
| William K Daniel | 이사 | 2026년 6월 12일 A | 7,641 | 1 | 0 | $691,900 |
| Bradley T Sheares | 이사 | 2026년 3월 6일 A | 47,623 | 0 | 0 | $0 |
| Philip A Laskawy | 이사 | 2026년 3월 6일 A | 24,538 | 0 | 1 | $-228,544 |
| Reed Vaughn Tuckson | 이사 | 2025년 6월 11일 F | 9,943 | 0 | 0 | $0 |
| Carol Raphael | 이사 | 2025년 5월 21일 F | 33,538 | 0 | 0 | $0 |
| Anne H. Margulies | 이사 | 2025년 3월 5일 F | 20,576 | 0 | 0 | $0 |
| Scott Philip Serota | 이사 | 2025년 3월 4일 A | 8,213 | 0 | 0 | $0 |
| Carole T Faig | 이사 | 2025년 3월 4일 A | 5,448 | 0 | 0 | $0 |
| Mohamad Ali | 이사 | 2025년 3월 4일 A | 12,498 | 0 | 0 | $0 |
| Robert J. Hombach | 이사 | 2025년 3월 4일 A | 2,844 | 0 | 0 | $0 |
| Steven Paladino | 이사 | 2024년 3월 4일 A | 138,272 | 0 | 0 | $0 |
| Dianne E Rekow | 이사 | 2022년 3월 16일 A | 18,526 | 0 | 0 | $0 |
| Barry J Alperin | 이사 | 2022년 3월 16일 A | 52,473 | 0 | 0 | $0 |
| Paul Brons | 이사 | 2021년 3월 3일 F | 16,854 | 0 | 0 | $0 |
| Shira Goodman | 이사 | 2021년 3월 3일 A | 5,689 | 0 | 0 | $0 |
| Lawrence S Bacow | 이사 | 2018년 3월 6일 F | 10,115 | 0 | 0 | $0 |
| Donald J Kabat | 이사 | 2018년 3월 6일 F | 10,874 | 0 | 0 | $0 |
| Louis W Sullivan | 이사 | 2016년 3월 31일 A | 14,096 | 0 | 0 | $0 |
| Norman S Matthews | 이사 | 2016년 3월 31일 A | 12,890 | 0 | 0 | $0 |
| Karyn Mashima | 이사 | 2014년 3월 10일 F | 19,269 | 0 | 0 | $0 |
| Irving Shafran | 이사 | 2003년 11월 20일 S | 750,000 | 0 | 0 | $0 |
| HENRY SCHEIN INC | 10% 소유주 | 2019년 2월 7일 J | 0 | 0 | 0 | $0 |
| Stanley M Bergman | — | 2026년 5월 26일 G | 253,279 | 0 | 5 | $-7,544,687 |
| Kurt P Kuehn | — | 2026년 3월 10일 S | 15,420 | 0 | 1 | $-224,562 |
| Deborah Derby | — | 2026년 3월 6일 A | 15,093 | 0 | 0 | $0 |
| Joseph L Herring | — | 2026년 3월 6일 A | 30,325 | 0 | 0 | $0 |
| Margaret A Hamburg | — | 2009년 5월 20일 M | 0 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 2 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 제출 서류 | 2026년 3월 10일 | 16.40% | 수정본 | — | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 제출 서류 | 2025년 8월 8일 | 13.00% | 수정본 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 124 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1.69% | 150,301 SH | 2026년 8월 8일 | 일간 |
| FLV · AMERICAN CENTURY ETF TRUST | 1.67% | 76,819 NS | 2026년 5월 31일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.31% | 154,050 NS | 2026년 4월 30일 | N-PORT |
| GURU · Global X Funds | 1.05% | 8,187 NS | 2026년 4월 30일 | N-PORT |
| TAX · EA Series Trust | 0.98% | 3,244 NS | 2026년 5월 29일 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.64% | 123,268 SH | 2026년 8월 8일 | 일간 |
| SMMV · iShares Trust | 0.60% | 19,668 SH | 2026년 8월 8일 | 일간 |
| FBCV · FIDELITY COVINGTON TRUST | 0.35% | 7,509 NS | 2026년 4월 30일 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.31% | 13,083 NS | 2026년 4월 30일 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 17,947 NS | 2026년 4월 30일 | N-PORT |
| ANEW · ProShares Trust | 0.28% | 283 NS | 2026년 5월 31일 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.28% | 55,872 SH | 2026년 8월 8일 | 일간 |
| ISCV · iShares Trust | 0.26% | 20,602 SH | 2026년 8월 8일 | 일간 |
| DEUS · DBX ETF Trust | 0.22% | 7,905 NS | 2026년 5월 29일 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.22% | 4,614 NS | 2026년 5월 31일 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 2,354,606 SH | 2026년 8월 8일 | 일간 |
| DFVE · DoubleLine ETF Trust | 0.21% | 765 NS | 2026년 3월 31일 | N-PORT |
| SPXD · DBX ETF Trust | 0.20% | 181 NS | 2026년 5월 31일 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.20% | 16,567 NS | 2026년 4월 30일 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.18% | 245 NS | 2026년 5월 31일 | N-PORT |
| ESML · iShares Trust | 0.18% | 58,273 SH | 2026년 8월 8일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.18% | 333,590 NS | 2026년 4월 30일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 55,767 NS | 2026년 4월 30일 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.17% | 1,416,056 SH | 2026년 8월 8일 | 일간 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 42,689 NS | 2026년 4월 30일 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.14% | 270,326 NS | 2026년 5월 31일 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.14% | 4,118 NS | 2026년 4월 30일 | N-PORT |
| IYH · iShares Trust | 0.14% | 58,901 SH | 2026년 8월 8일 | 일간 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.14% | 24,631 NS | 2026년 4월 30일 | N-PORT |
| ISCB · iShares Trust | 0.13% | 4,208 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 48,980 NS | 2026년 4월 30일 | N-PORT |
| NUSC · Nushares ETF Trust | 0.12% | 21,075 NS | 2026년 4월 30일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.12% | 293,098 SH | 2026년 8월 8일 | 일간 |
| SMMD · iShares Trust | 0.12% | 49,577 SH | 2026년 8월 8일 | 일간 |
| RXL · ProShares Trust | 0.11% | 1,043 NS | 2026년 5월 31일 | N-PORT |
| IXJ · iShares Trust | 0.11% | 51,636 SH | 2026년 8월 8일 | 일간 |
| CURE · Direxion Shares ETF Trust | 0.11% | 1,994 NS | 2026년 4월 30일 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.10% | 2,230,411 SH | 2026년 8월 8일 | 일간 |
| IEDI · iShares U.S. ETF Trust | 0.10% | 316 SH | 2026년 8월 8일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 9,299 SH | 2026년 8월 8일 | 일간 |
| VFMF · VANGUARD WELLINGTON FUND | 0.09% | 7,550 SH | 2026년 8월 8일 | 일간 |
| IWS · iShares Trust | 0.08% | 148,171 SH | 2026년 8월 8일 | 일간 |
| DFAT · Dimensional ETF Trust | 0.08% | 146,387 NS | 2026년 4월 30일 | N-PORT |
| WSML · iShares Trust | 0.08% | 5,958 SH | 2026년 8월 8일 | 일간 |
| TILT · FlexShares Trust | 0.08% | 20,790 NS | 2026년 4월 30일 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.07% | 82,484 SH | 2026년 8월 8일 | 일간 |
| VFVA · VANGUARD WELLINGTON FUND | 0.07% | 7,214 SH | 2026년 8월 8일 | 일간 |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 6,605 NS | 2026년 4월 30일 | N-PORT |
| IWR · iShares Trust | 0.06% | 401,448 SH | 2026년 8월 8일 | 일간 |
| JSTC · Tidal Trust I | 0.06% | 2,708 NS | 2026년 5월 31일 | N-PORT |